Stem Cell Innovations (fka SCLL)

[califax]

...Reason for AS-raising:

http://ih.advfn.com/p.php?pid=nmona&cb=1263418489&article=38506674&symbol=NO^SCLL


Because the Company only has 4 billion authorized shares of common stock, of which 1,681,137,312 shares are issued and outstanding, and because $1 million of Ms. Chassman’s convertible notes (or Series 3 Stock) issued by the Company are now convertible into 5 billion shares of its common stock, full conversion of these notes (or shares of Series 3 Stock) also requires that the Company increase the number of shares of common stock it is authorized to issue. Accordingly, the Company is seeking approval of the second Amendment, which will increase the authorized shares of common stock from 4 billion to 20 billion.

################################################################################################

As of June 24, 2009, there were outstanding 1,681,137,312 shares of our common stock...
http://ih.advfn.com/p.php?pid=nmona&cb=1263418489&article=38506674&symbol=NO^SCLL

(As of Jan, 2010), there are currently 2,844,387,312 shares issued and outstanding...
http://ih.advfn.com/p.php?pid=nmona&cb=1263418830&article=41095210&symbol=NO^SCLL